Fierce Pharma

With a resounding unanimous vote, the U.S. Supreme Court has [...]

The drumbeat of news regarding Asian pharma—and particularly China—continues to [...]

Three times as many deaths in the study arm versus [...]

The company inked another settlement with a prospective generic maker, [...]

Medical device distribution giant Medline has been slammed for a [...]

In response to a planned healthcare reform initiative in Germany [...]

As its ultra-rare disease med Miplyffa strengthens its foothold in [...]

Cencora and Gilead have expanded their longstanding partnership, cutting a [...]

After a prior misfire in demonstrating its protease inhibitor ensitrelvir’s [...]

HER2 combination strategies are evolving. Hear how biology and next-generation [...]